Medtronic has received clearance from the US Food and Drug Administration (FDA) for expanded indications of the Vertex reconstruction system. The new clearance for the Vertex family of products allows for lateral mass and pedicle screws to be used as a form of fixation to treat various pathologies occurring in the posterior cervical spine, making it one of the first FDA-cleared systems available in the USA for use of screws at C1–C7.
“This clearance opens up new opportunities for collaboration with medical device companies such as Medtronic to create a sound foundation on which we can advance current techniques, create new solutions, and deliver the next level of care to our patients,” says Vincent Traynelis, neurosurgeon at Rush University in Chicago, USA.
Doug King, president of the spinal business and senior vice president of Medtronic, comments, “Medtronic can now partner with physicians and professional spine societies to provide the most productive educational experiences to further understand and enhance the various techniques for treating conditions in the posterior cervical spine. This achievement is an exciting time for the spinal industry, and we are thrilled to be a part of the advancement in procedural innovation and portfolio expansion.”
